Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02414438 · ClinicalTrials.gov registry record · NA
Establishing the Clinical Utility of First StepDx PLUS and NextStepDx PLUS Study
A NA study, sponsored by Qure Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 217
- Enrollment target
NCT02414438 is a NA study that has completed, run by Qure Healthcare. The registered enrollment target is 217 participants.
The verdict
NCT02414438, a NA study, has completed, sponsored by Qure Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 217 participants
- Enrollment target
Study Summary
The study uses a randomized controlled study design of pediatric neurologists and developmental pediatricians and front-line (primary care) pediatricians to determine if use of FirstStepDx PLUS and Next StepDx PLUS are associated with higher clinical quality, less variability in clinical practice, and lower costs from decreased resource utilization. The Clinical Performance and Value Vignettes (CPV) used in this study simulate a clinical encounter for individuals with an atypical phenotype and clinical presentation indicative of a possible genetic disorder. We will measure the difference in combined diagnostic and treatment CPV® domain score post-intervention versus baseline comparing intervention and control groups
Interventions
- OTHER FirstStepDX PLUS and NextStepDX PLUS Webinar
- OTHER FirstStepDX PLUS and NextStepDX PLUS Test Results
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 217 participants |
| Start Date | 2014-08 |
| Est. Completion | 2015-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02414438
The ClinicalTrials.gov registry entry for NCT02414438 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 217 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Qure Healthcare, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which FirstStepDX PLUS and NextStepDX PLUS Webinar is the first listed.
NCT02414438 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02414438 about?
NCT02414438 is a clinical study titled "Establishing the Clinical Utility of First StepDx PLUS and NextStepDx PLUS Study". The study uses a randomized controlled study design of pediatric neurologists and developmental pediatricians and front-line (primary care) pediatricians to determine if use of FirstStepDx PLUS and Next StepDx PLUS are associated with higher clinical quality, less variability in clinical practice, a...
What is the current status of trial NCT02414438?
This trial is currently completed. It is a NA study. The enrollment target is 217 participants. The study started on 2014-08. Estimated completion is 2015-01.
What interventions are being tested in trial NCT02414438?
The interventions under investigation include: FirstStepDX PLUS and NextStepDX PLUS Webinar (OTHER), FirstStepDX PLUS and NextStepDX PLUS Test Results (OTHER).
Who is sponsoring clinical trial NCT02414438?
This trial is sponsored by Qure Healthcare, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.